Alembic Pharmaceuticals reports marginal fall in Q3 consolidated net profit

05 Feb 2026 Evaluate

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 33.40% rise in its net profit at Rs 114.47 crore for the third quarter ended December 31, 2025 as compared to Rs 85.81 crore for the same quarter in the previous year. Total income of the company increased by 16.28% at Rs 1652.97 crore for Q3FY26 as compared to Rs 1421.55 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 3.93% fall in its net profit at Rs 132.97 crore for the third quarter ended December 31, 2025 as compared to Rs 138.42 crore for the same quarter in the previous year. However, total income of the company increased by 11.13% at Rs 1891.81 crore for Q3FY26 as compared to Rs 1702.25 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

788.00 -21.75 (-2.69%)
06-Feb-2026 12:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.00
Dr. Reddys Lab 1229.00
Cipla 1323.35
Zydus Lifesciences 888.10
Lupin 2180.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×